12 completed, 1 terminated. 9 Phase 1, 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow K-877 compound: new trials by email Literature Review of K-877 compound trials Research Report on K-877 compound
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Food Effect of K-877 in Healthy Adult Volunteers K-877 - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 18 | 2021-01-13 | 2021-08-09 |
| Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers K-877, CSG452 - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2019-12-17 | 2020-09-22 |
| A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) K-877, Placebo - Non-Alcoholic Fatty Liver Disease | Phase 2 | Completed | Kowa Company, Ltd. | 118 | 2017-12-27 | 2021-04-09 |
| Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) K-877, Placebo - Type2 Diabetes, Dyslipidemia | Phase 3 | Terminated | Kowa Research Institute, Inc. | 10544 | 2017-03-23 | 2025-09-25 |
| Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia | Phase 3 | Completed | Kowa Research Institute, Inc. | 551 | 2016-11-28 | 2022-11-30 |
| Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment K-877, Fenofibrate, Placebo (for K-877) - Severe Hypertriglyceridemia | Phase 3 | Completed | Kowa Research Institute, Inc. | 471 | 2016-11-26 | 2022-10-28 |
| Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers K-877, Clopidogrel - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2016-09-01 | 2016-12-21 |
| Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers Warfarin, K-877 - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2016-01-01 | 2016-03-25 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers K-877, Rifampin - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2014-09-01 | 2016-02-01 |
| Drug-Drug Interaction Study in Health Adult Volunteers Digoxin, K-877 - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2014-08-01 | 2014-10-24 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers K-877, Fluconazole - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2014-07-01 | 2014-10-27 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers K-877, Cyclosporine - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2014-06-01 | 2014-10-27 |
| Drug-Drug Interaction Study in Healthy Adult Volunteers K-877, Clarithromycin - Healthy | Phase 1 | Completed | Kowa Research Institute, Inc. | 20 | 2014-06-01 | 2014-10-27 |
Hypertriglyceridemia (2) · Dyslipidemias (1) · Non-alcoholic Fatty Liver Disease (1)
Kowa Research Institute, Inc. (12) · Kowa Company, Ltd. (1)
United States (12) · Bulgaria (3) · Czechia (3) · Hungary (3) · Poland (3) · Russia (3) · Ukraine (3) · Belarus (2) · Georgia (2) · Japan (2) · Argentina (1) · Brazil (1) · Canada (1) · Colombia (1) · Denmark (1)
Stuart Campbell (5) · Aruna Pradhan, MD (1) · Paul Ridker, MD (1) · Ryohei Tanigawa (1) · Shona Pendse, MD, MMSc (1)
PMID 30342298, PMID 33392801, PMID 34528723, PMID 36342113, PMID 41953251